No abstract

Researchers in embedded and reconfigurable computing are often hindered by a lack of suitable benchmarks with which to accurately evaluate their work. Without a suitable benchmark suite, researchers use either outdated, unrealistic benchmarks or spend valuable time creating their own. In this paper, we present ERCBench-a freely-available, open-source benchmark suite geared towards embedded and reconfigurable computing research. ERCBench benchmarks represent a variety of application areas, including multimedia processing, wireless communications, and cryptography. They consist of synthesizable Verilog models for hardware accelerators and hybrid hardware/software applications that combine softwarebased control flow with hardware-based computation tasks.

No abstract

Objective: To determine whether an effective opioid-sparing pain control modality is desirable for an aging population. Design: Retrospective observational study Setting: Academic medical center Patients: 192 patients with various types of fragility hip fractures Intervention: A single-injection femoral nerve block (FNB) Main outcome measurements: Pain score, opioid consumption Results: We observed statistically significant effects of FNB on visual analogue scale pain score and the rate of opioid consumption diminution in all commonly encountered types of fragility hip fractures. The pain score reduction by FNB in subcapital femoral neck fracture, transcervical femoral neck facture, and intertrochanteric fracture are all statistically significant (P < 0.0001). There was a statistically more significant pain score reduction in intracapsular fractures than in extracapsular fractures (P = 0.006). On average, the hip fracture patients required 0.9 and 0.1 mg morphine equivalent/hour before and after FNB block placement. This decrease in opioid consumption when calculated per unit time was statistically significant in subcapital femoral neck fracture, transcervical femoral neck facture, and intertrochanteric fracture (P < 0.0001). There were no complications related to FNB placement. Conclusions: FNB is a sustainable, safe, and useful analgesic modality for commonly encountered fragility hip fractures. Level of Evidence: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.